Komori
Pharma Foods International (2929) · RiskWorsened

Guarantee Obligations to Affiliates and Business Partners

First written in FY2016-Q3. 10 of 15 entries say "Mitigated", first in FY2017-Q1. Latest entry: FY2026.

15entries
11years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseMitigatedFY2017-Q1 – FY2019WorsenedFY2023 – FY20262016: 220162017: 320172018: 320182019: 320192020: 020202021: 020212022: 020222023: 120232024: 120242025: 020252026: 22026
Same theme, other companies
Guarantee Obligations for Borrowings and Transaction Performance Involving Affiliated Companies and Other EntitiesA theme 12 companies write about · 12 as a headwind · 0 as a tailwind

Pharma Foods International moved to the "Worse" side of this theme in 2023, 3 years before the typical company in this theme (2026).

The whole theme swung hardest in 2026: 8 of 9 companies on the "Worse" side.

6 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「The Company provides guarantees for borrowings by 明治薬品㈱ from financial institutions. ¥4,230 million」

    Guarantees provided for 明治薬品 increased from ¥1,190 million in the previous fiscal year to ¥4,230 million.
  2. 2026-10-02WorsenedGeneral Meetings of Shareholders

    「Meiji Pharmaceutical Co., Ltd. ¥4,230 million」

    The amount of debt guarantees provided for Meiji Pharmaceutical was ¥4,230 million, up from ¥1,250 million reported in previous securities reports.
  3. FY2024WorsenedAnnual report

    「明治薬品㈱ ¥1,250 million」

    The guarantee obligation for borrowings by 明治薬品 from financial institutions increased from ¥1,000 million in the previous fiscal year to ¥1,250 million.
  4. FY2023MaterialisedAnnual report

    「明治薬品㈱ — million yen ¥1,000 million」

    A ¥1,000 million guarantee obligation for borrowings by 明治薬品 from financial institutions was newly recorded, compared with zero guarantee obligations in the previous fiscal year.
  5. FY2019MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) — Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) — Total ¥439,914 thousand —」

    Guarantee obligations of ¥439,914 thousand at the end of the previous consolidated fiscal year became zero at the end of the current consolidated fiscal year.
  6. FY2019-Q3MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥356,348 thousand Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) — — thousand Total ¥356,348 thousand」

    Total guarantee obligations decreased from ¥439,914 thousand at the end of the previous consolidated fiscal year to ¥356,348 thousand, and Pulmuone Health & Living Co.,Ltd.'s payment guarantee became zero.
  7. FY2019-Q2MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥369,792 thousand　— ¥0 thousand　Total ¥369,792 thousand」

    Total guarantee obligations decreased from ¥439,914 thousand at the end of the previous consolidated fiscal year to ¥369,792 thousand, and Pulmuone Health & Living Co.,Ltd.'s payment guarantee became zero.
  8. FY2019-Q1MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥389,958 thousand Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥29,850 thousand Total ¥419,808 thousand」

    Total guarantee obligations decreased from ¥439,914 thousand at the end of the previous consolidated fiscal year to ¥419,808 thousand.
  9. FY2018-Q3MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥433,651 thousand Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥30,540 thousand Total ¥464,191 thousand」

    Total guarantee obligations decreased from ¥520,248 thousand at the end of the previous consolidated fiscal year to ¥464,191 thousand.
  10. FY2018-Q2MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥450,456 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥30,480 thousand　Total ¥480,936 thousand」

    Total guarantee obligations decreased from ¥520,248 thousand at the end of the previous consolidated fiscal year to ¥480,936 thousand.
  11. FY2018-Q1MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥470,622 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥30,270 thousand　Total ¥500,892 thousand」

    Total guarantee obligations decreased from ¥520,248 thousand at the end of the previous consolidated fiscal year to ¥500,892 thousand.
  12. FY2017-Q3MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥517,676 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥29,640 thousand　Total ¥547,316 thousand」

    Total guarantee obligations decreased from ¥606,104 thousand at the end of the previous consolidated fiscal year and ¥560,160 thousand in the previous quarter to ¥547,316 thousand.
  13. FY2017-Q2MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥531,120 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥29,040 thousand　Total ¥560,160 thousand」

    Total guarantee obligations decreased from ¥606,104 thousand at the end of the previous consolidated fiscal year to ¥560,160 thousand.
  14. FY2017-Q1MitigatedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥551,286 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩300,000,000) ¥27,450 thousand　Total ¥578,736 thousand」

    Total guarantee obligations decreased from ¥606,104 thousand at the end of the previous consolidated fiscal year to ¥578,736 thousand.
  15. FY2016-Q3First statedAnnual report

    「ベナート株式会社 (bank loan guarantee) ¥598,340 thousand　Pulmuone Health & Living Co.,Ltd. (payment guarantee of ₩360,000,000) ¥34,524 thousand　Total ¥632,864 thousand」

    Guarantee obligations comprising bank loan and payment guarantees were disclosed at ¥632,864 thousand.
Moved together

" 적극ive efforts under the Foods with Function Claims system" moved the same way as this thread, in the same document, in 8 of its 15 moves.

876544★123456
  1. ★This thread
  2. 1 적극ive efforts under the Foods with Function Claims system8×
  3. 2Functional Materials business: lower revenue and profit7×
  4. 3Commercialization and Development Pipeline for New Functional Materials6×
  5. 4Higher revenue and narrower loss in the biomedical business5×
  6. 5Advertising Investment and Product Brand Expansion in Mail-Order Sales4×
  7. 6Revenue Growth and Return to Profitability in the Mail-Order Business4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Pharma Foods International yet. It last moved in the General Meetings of Shareholders of 2026-10-02: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Guarantee Obligations to Affiliates and Business Partners | Pharma Foods International Co.,Ltd. (2929) | Komori